Taiwan · Delayed Price · Currency is TWD Handa Pharmaceuticals Statistics
Total Valuation
TPEX:6620 has a market cap or net worth of TWD 18.37 billion. The enterprise value is 14.68 billion.
| Market Cap | 18.37B |
| Enterprise Value | 14.68B |
Important Dates
The next estimated earnings date is Friday, December 4, 2026.
| Earnings Date | Dec 4, 2026 |
| Ex-Dividend Date | Jul 6, 2026 |
Share Statistics
TPEX:6620 has 162.53 million shares outstanding. The number of shares has increased by 10.82% in one year.
| Current Share Class | 162.53M |
| Shares Outstanding | 162.53M |
| Shares Change (YoY) | +10.82% |
| Shares Change (QoQ) | -2.22% |
| Owned by Insiders (%) | 1.55% |
| Owned by Institutions (%) | 2.19% |
| Float | 93.01M |
Valuation Ratios
The trailing PE ratio is 37.44 and the forward PE ratio is 23.40.
| PE Ratio | 37.44 |
| Forward PE | 23.40 |
| PS Ratio | 15.17 |
| PB Ratio | 3.66 |
| P/TBV Ratio | 4.25 |
| P/FCF Ratio | 29.00 |
| P/OCF Ratio | 27.74 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.80, with an EV/FCF ratio of 23.18.
| EV / Earnings | 29.95 |
| EV / Sales | 12.12 |
| EV / EBITDA | 23.80 |
| EV / EBIT | 32.44 |
| EV / FCF | 23.18 |
Financial Position
The company has a current ratio of 8.97, with a Debt / Equity ratio of 0.01.
| Current Ratio | 8.97 |
| Quick Ratio | 8.88 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.07 |
| Debt / FCF | 0.06 |
| Interest Coverage | 416.39 |
Financial Efficiency
Return on equity (ROE) is 10.60% and return on invested capital (ROIC) is 24.98%.
| Return on Equity (ROE) | 10.60% |
| Return on Assets (ROA) | 5.53% |
| Return on Invested Capital (ROIC) | 24.98% |
| Return on Capital Employed (ROCE) | 8.87% |
| Weighted Average Cost of Capital (WACC) | 7.93% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.24 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TPEX:6620 has paid 122.95 million in taxes.
| Income Tax | 122.95M |
| Effective Tax Rate | 20.05% |
Stock Price Statistics
The stock price has increased by +50.85% in the last 52 weeks. The beta is 0.67, so TPEX:6620's price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | +50.85% |
| 50-Day Moving Average | 88.30 |
| 200-Day Moving Average | 85.48 |
| Relative Strength Index (RSI) | 74.28 |
| Average Volume (20 Days) | 1,673,262 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6620 had revenue of TWD 1.21 billion and earned 490.22 million in profits. Earnings per share was 3.02.
| Revenue | 1.21B |
| Gross Profit | 985.90M |
| Operating Income | 453.87M |
| Pretax Income | 613.17M |
| Net Income | 490.22M |
| EBITDA | 604.86M |
| EBIT | 453.87M |
| Earnings Per Share (EPS) | 3.02 |
Balance Sheet
The company has 3.73 billion in cash and 41.03 million in debt, with a net cash position of 3.69 billion or 22.68 per share.
| Cash & Cash Equivalents | 3.73B |
| Total Debt | 41.03M |
| Net Cash | 3.69B |
| Net Cash Per Share | 22.68 |
| Equity (Book Value) | 5.02B |
| Book Value Per Share | 30.90 |
| Working Capital | 3.71B |
Cash Flow
In the last 12 months, operating cash flow was 662.01 million and capital expenditures -28.72 million, giving a free cash flow of 633.29 million.
| Operating Cash Flow | 662.01M |
| Capital Expenditures | -28.72M |
| Depreciation & Amortization | 150.99M |
| Net Borrowing | -13.24M |
| Free Cash Flow | 633.29M |
| FCF Per Share | 3.90 |
Margins
Gross margin is 81.41%, with operating and profit margins of 37.48% and 40.48%.
| Gross Margin | 81.41% |
| Operating Margin | 37.48% |
| Pretax Margin | 50.63% |
| Profit Margin | 40.48% |
| EBITDA Margin | 49.95% |
| EBIT Margin | 37.48% |
| FCF Margin | 52.29% |
Dividends & Yields
This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 2.04%.
| Dividend Per Share | 2.00 |
| Dividend Yield | 2.04% |
| Dividend Growth (YoY) | 37.63% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 48.20% |
| Buyback Yield | -10.82% |
| Shareholder Yield | -8.77% |
| Earnings Yield | 2.67% |
| FCF Yield | 3.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPEX:6620 has an Altman Z-Score of 17.1 and a Piotroski F-Score of 4.
| Altman Z-Score | 17.1 |
| Piotroski F-Score | 4 |